Alphabet’s Isomorphic Labs announced on May 21, 2026, the expansion of its partnership with Eli Lilly and Company to utilize AlphaFold 3 for accelerated drug
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.